HEART DISEASE SUPPORT
IV EDTA Chelation · IV Plaquex · Free Heart Screening · NIH TACT Trial
A Different Approach to Cardiovascular Health — Backed by a Major NIH Clinical Trial
Heart disease is the #1 killer in America. While standard cardiology focuses on medications, stents, and bypass surgery, KIM offers IV EDTA Chelation Therapy and IV Plaquex Phospholipid Therapy — approaches addressing the underlying biochemical and vascular environment contributing to arterial disease.
This is backed by science: the NIH funded a rigorous 1,708-patient randomized controlled trial — the TACT Study, published in JAMA — demonstrating statistically significant cardiovascular benefits for IV chelation therapy, particularly in diabetic patients. Lead investigator: Harvard-educated cardiologist Dr. Gervasio Lamas, MD. Result summary below.
18%
Reduction in major cardiovascular events — non-diabetic patients (NIH TACT Trial, JAMA)
41%
Reduction in major cardiovascular events — diabetic patients (NIH TACT Trial, JAMA)
26%
Reduction in coronary revascularization procedures (NIH TACT Trial)
1,708
Patients enrolled in this NIH-sponsored randomized controlled trial
IV EDTA Chelation Therapy
EDTA is administered IV over ~1.5 hours per session. IV chelation is FDA-approved for heavy metal burdens (lead, mercury, arsenic, cadmium, etc.); IV chelation for cardiovascular use is off-label and investigational, supported by TACT trial data. Proposed mechanisms include removal of heavy metals that catalyze oxidative damage and improvement in vascular function. Typical cardiovascular protocol: 40–60 sessions over 1–2 years.
IV Plaquex (Phosphatidylcholine)
IV Plaquex delivers essential phospholipids — the building blocks of healthy cell membranes — directly into the bloodstream. Used supportively for cardiovascular disease, fatty liver, peripheral artery disease, and cellular aging. Off-label therapy- NOT FDA approved.
Get Back to Feeling Good!
Our treatment approaches transform lives from dysfunctional to functional.
SERVICE
INVESTMENT
IV EDTA Chelation — per session
$130 – $175
IV Plaquex — per session
$175
Full Cardiovascular Protocol (40–60 sessions)
$4,000 – $8,000
Advanced Heart Hospital Screening includes: 1] Heart artery calcium score, 2] Ultrasound of Carotids and Aorta, 3] ABI test -Leg Blood Flow.
$150 – $200
Call our office 812-913-4416 for FREE prescription, testing interpretation, and consultation.
REGULATORY NOTICE
IV EDTA Chelation is FDA-approved ONLY for heavy metal toxicity. Cardiovascular use is off-label and investigational. IV Plaquex is not FDA-approved in the U.S. The NIH TACT trial showed significant benefits in specific subgroups; results cannot be universally generalized. These therapies are not covered by insurance and are not a substitute for standard cardiology care. Individual results vary.
